ATE315645T1 - Dns oder gene, die an der parkinsonschen krankheit beteiligt sind - Google Patents
Dns oder gene, die an der parkinsonschen krankheit beteiligt sindInfo
- Publication number
- ATE315645T1 ATE315645T1 AT99902859T AT99902859T ATE315645T1 AT E315645 T1 ATE315645 T1 AT E315645T1 AT 99902859 T AT99902859 T AT 99902859T AT 99902859 T AT99902859 T AT 99902859T AT E315645 T1 ATE315645 T1 AT E315645T1
- Authority
- AT
- Austria
- Prior art keywords
- disease
- parkinson
- dna
- genes involved
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2753198 | 1998-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE315645T1 true ATE315645T1 (de) | 2006-02-15 |
Family
ID=12223704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99902859T ATE315645T1 (de) | 1998-02-09 | 1999-02-09 | Dns oder gene, die an der parkinsonschen krankheit beteiligt sind |
Country Status (10)
Country | Link |
---|---|
US (2) | US6716621B1 (de) |
EP (1) | EP1063294B1 (de) |
JP (1) | JP4430815B2 (de) |
AT (1) | ATE315645T1 (de) |
AU (1) | AU2299999A (de) |
CA (1) | CA2320220C (de) |
DE (2) | DE1063294T1 (de) |
DK (1) | DK1063294T3 (de) |
ES (1) | ES2257029T3 (de) |
WO (1) | WO1999040191A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775984B1 (fr) * | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
WO1999040191A1 (fr) * | 1998-02-09 | 1999-08-12 | Boehringer Ingelheim International Gmbh | Adn ou genes contribuant au developpement de la maladie de parkinson |
DE69941300D1 (de) * | 1998-11-19 | 2009-10-01 | Aventis Pharma Sa | Fahren und verwendungen |
CA2996759A1 (fr) | 1998-11-19 | 2000-06-02 | Aventis Pharma S.A. | Mutations du gene de la parkine, compositions, methodes et utilisations |
EP1081225A1 (de) * | 1999-08-30 | 2001-03-07 | Biofrontera Pharmaceuticals GmbH | Transgenes Tiermodel für neurodegenerative Erkrankungen |
WO2001062957A1 (fr) * | 2000-02-24 | 2001-08-30 | Boehringer Ingelheim International Gmbh | Proteine parkine utilisee comme ubiquitine ligase |
US7399900B2 (en) | 2000-03-22 | 2008-07-15 | Sanofi-Aventis Deutschland Gmbh | Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode gene |
US7070940B2 (en) * | 2002-07-18 | 2006-07-04 | Aventis Pharma S.A. | Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein |
TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
US8697082B2 (en) | 2002-11-01 | 2014-04-15 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
US20080014194A1 (en) | 2003-10-31 | 2008-01-17 | Elan Pharmaceuticals, Inc. | Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease |
US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
US7358331B2 (en) | 2003-05-19 | 2008-04-15 | Elan Pharmaceuticals, Inc. | Truncated fragments of alpha-synuclein in Lewy body disease |
US7674599B2 (en) | 2003-11-08 | 2010-03-09 | Elan Pharmaceuticals, Inc. | Methods of using antibodies to detect alpha-synuclein in fluid samples |
WO2008095126A2 (en) | 2007-01-31 | 2008-08-07 | Elan Pharma International Limited | Assays for modulators of parkin activity using novel substrates |
DK3067066T3 (da) | 2007-02-23 | 2019-05-20 | Prothena Biosciences Ltd | Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom |
US8147833B2 (en) | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999040191A1 (fr) * | 1998-02-09 | 1999-08-12 | Boehringer Ingelheim International Gmbh | Adn ou genes contribuant au developpement de la maladie de parkinson |
-
1999
- 1999-02-09 WO PCT/JP1999/000545 patent/WO1999040191A1/ja active IP Right Grant
- 1999-02-09 AT AT99902859T patent/ATE315645T1/de active
- 1999-02-09 EP EP99902859A patent/EP1063294B1/de not_active Expired - Lifetime
- 1999-02-09 AU AU22999/99A patent/AU2299999A/en not_active Abandoned
- 1999-02-09 CA CA2320220A patent/CA2320220C/en not_active Expired - Fee Related
- 1999-02-09 JP JP2000530605A patent/JP4430815B2/ja not_active Expired - Fee Related
- 1999-02-09 ES ES99902859T patent/ES2257029T3/es not_active Expired - Lifetime
- 1999-02-09 US US09/601,844 patent/US6716621B1/en not_active Expired - Fee Related
- 1999-02-09 DK DK99902859T patent/DK1063294T3/da active
- 1999-02-09 DE DE1063294T patent/DE1063294T1/de active Pending
- 1999-02-09 DE DE69929417T patent/DE69929417T2/de not_active Expired - Lifetime
-
2004
- 2004-02-12 US US10/776,604 patent/US20050003385A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2299999A (en) | 1999-08-23 |
WO1999040191A1 (fr) | 1999-08-12 |
DE1063294T1 (de) | 2003-06-26 |
EP1063294A4 (de) | 2002-01-16 |
JP4430815B2 (ja) | 2010-03-10 |
CA2320220A1 (en) | 1999-08-12 |
US6716621B1 (en) | 2004-04-06 |
US20050003385A1 (en) | 2005-01-06 |
DE69929417T2 (de) | 2006-08-03 |
EP1063294A1 (de) | 2000-12-27 |
DE69929417D1 (de) | 2006-04-06 |
ES2257029T3 (es) | 2006-07-16 |
EP1063294B1 (de) | 2006-01-11 |
CA2320220C (en) | 2011-08-02 |
DK1063294T3 (da) | 2006-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE315645T1 (de) | Dns oder gene, die an der parkinsonschen krankheit beteiligt sind | |
DK1013661T3 (da) | 2'-O,4'-metylen bicyklonukleosid | |
ES2066760T3 (es) | Nucleotidos de alquinilamino. | |
DE69840748D1 (de) | Verfahren zur zubereitung von antisense oligonukleotiden | |
ATE277068T1 (de) | 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind | |
ATE340869T1 (de) | Massenmarkierte hybridisierungssonden | |
DE69719220D1 (de) | Neue nucleotidanaloga | |
EP1108724A3 (de) | Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle | |
DE69825253D1 (de) | Verfahren für die herstellung von 1,1,1,3,3-pentafluorpropen und 2-chlor-pentafluorpropen | |
BR9912951A (pt) | Método de fabricação de nucleotìdoes de 1,3-oxatiolano | |
DE69736840D1 (de) | Synthese von nukleosiden und polynukleotiden | |
WO2001000661A3 (en) | Carnitine carrier related protein-1 | |
DE69816059D1 (de) | Gen, das für das pyruvat dehydrogenase kinase von pflanzen kodiert | |
ATE401403T1 (de) | Nukleotidsequenzen, die an erhöhung oder verringerung von der ovulationsgeschwindigkeit in säugertieren beteiligt sind | |
DE69402201D1 (de) | Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen | |
NO995858D0 (no) | Ny klasse kationiske nukleinsyre-overföringsmidler | |
DE59809600D1 (de) | Doppelmetallcyanid-katalysatoren für die herstellung von polyetherpolyolen | |
ATE270331T1 (de) | Rezeptor und dafür kodierendes nukleinsäuremolekül | |
DE3851045D1 (de) | Träger für DNS-Hybridisierung. | |
BR9801379A (pt) | Processo de preparação de dinitroanilinas dissubstituidas em 3,4 | |
ATE495027T1 (de) | Werkzeug zur herstellung dekorativer muster auf einem beschichtungsmaterial | |
BR9901948B1 (pt) | processo de curtimento de couros com compostos carbonÍlicos. | |
BR9704100B1 (pt) | processo para recuperaÇço de acrilonitrila ou metacrilonitrila. | |
IT241798Y1 (it) | Finitura superficiale su oggetti in metallo prezioso o non, prodottimediante elettroformatura nell'industria orafa o simile. | |
ITTO20020364A1 (it) | Deposito autocertificazione;lettera d'incarico segue. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1063294 Country of ref document: EP |